Recombinant IL9 (Enokizumab Biosimilar) antibody
Quick Overview for Recombinant IL9 (Enokizumab Biosimilar) antibody (ABIN7487962)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Enokizumab Biosimilar - Anti-IL9 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL9 (Enokizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
7F3com-2H2,MEDI-528
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.
Target
-